T2	total-participants 503 506	956
T5	outcome-Measure 814 848	change in hot flushes at 12 months
T8	outcome 1208 1267	clinically relevant worsening in key symptoms and global Qo
T1	control 22 41	extended continuous
T3	intervention 49 80	intermittent adjuvant letrozole
T4	outcome 877 901	hot flushes at 12 months
T6	outcome 1067 1083	vaginal problems
T7	outcome 1085 1105	musculoskeletal pain
T9	outcome 1107 1124	sleep disturbance
T10	outcome 1126 1145	physical well-being
T11	outcome 1150 1154	mood
